• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Universe Pharmaceuticals Inc.

    2/11/22 8:00:43 AM ET
    $UPC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $UPC alert in real time by email
    SC 13G 1 ea155348-13gsun_universe.htm SCHEDULE 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO.    )*

     

    Universe Pharmaceuticals INC

    (Name of Issuer)

     

    Ordinary shares, $0.003125 par value per share

    (Title of Class of Securities)

     

    G9442G104**

    (CUSIP Number)

     

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☒ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    ** CUSIP number G9442G104 has been assigned to the ordinary shares (“Ordinary Shares”) of the Issuer, which are listed on the Nasdaq Global Market under the symbol “UPC.”

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. G9442G104    

     

    1

    Name of Reporting Person


    Sununion Holding Group Limited

    2

    Check the Appropriate Box if a Member of a Group

    (a)   ☐

    (b)   ☐

     

    3

    SEC Use Only

     

    4

    Citizenship or Place of Organization

    British Virgin Islands 

    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5

    Sole Voting Power

    0

    6

    Shared Voting Power

    12,480,000 (1)

    7

    Sole Dispositive Power

    0

    8

    Shared Dispositive Power

    12,480,000 (1)

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    12,480,000 (1)

    10

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐

     

    11

    Percent of Class Represented by Amount in Row 9

    57.38% (2)

    12 Type of Reporting Person
    FI

     

     

    (1) Represents 12,480,000 ordinary shares held by Sununion Holding Group Limited, a British Virgin Islands company owned as to 91.4% by Mr. Gang Lai.
       
    (2) The beneficial ownership percentage is calculated based on 21,750,000 ordinary shares of the Issuer issued and outstanding as of December 31, 2021.

     

     

     

     

    CUSIP No. G9442G104    

     

    1

    Name of Reporting Person

     

    Gang Lai

    2

    Check the Appropriate Box if a Member of a Group

    (a)   ☐

    (b)   ☐

     

    3

    SEC Use Only

     

    4

    Citizenship or Place of Organization

     

    Commonwealth of Dominica

    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5

    Sole Voting Power

    0

    6

    Shared Voting Power

    12,480,000 (1)

    7

    Sole Dispositive Power

    0

    8

    Shared Dispositive Power

    12,480,000 (1)

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    12,480,000 (1)

    10

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐

     

    11

    Percent of Class Represented by Amount in Row 9

    57.38%  (2)

    12

    Type of Reporting Person


    IN

     

     

    (1) Represents 12,480,000 ordinary shares held by Sununion Holding Group Limited, a British Virgin Islands company owned as to 91.4% by Mr. Gang Lai.
       
    (2) The beneficial ownership percentage is calculated based on 21,750,000 ordinary shares of the Issuer issued and outstanding as of December 31, 2021.

     

     

     

     

    ITEM 1.

     

      (a) Name of Issuer:

     

    Universe Pharmaceuticals INC

     

      (b) Address of Issuer’s Principal Executive Offices:

     

    265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone

    Ji’an, Jiangxi, People’s Republic of China 343100

     

    ITEM 2.

     

      (a) Name of Person Filing:

     

    (i)Sununion Holding Group Limited
    (ii)Gang Lai

     

    (collectively, the “Reporting Persons”) 

     

      (b) Address of Principal Business Office, or if None, Residence:

     

    The addresses of the Reporting Persons are:

     

    (i)Sununion Holding Group Limited

     

    Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands

     

    (ii)Gang Lai

     

    265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone

    Ji’an, Jiangxi, People’s Republic of China 343100

     

      (c) Citizenship:

     

    (i)Sununion Holding Group Limited

     

    British Virgin Islands

     

    (ii)Gang Lai

     

    Commonwealth of Dominica

     

      (d) Title of Class of Securities:

     

    Ordinary Shares, par value $0.003125 per share

     

      (e) CUSIP Number: G9442G104

     

     

     

     

    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
           
      (b) ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ☐ An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E);
           
      (f) ☐ An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F);
           
      (g) ☐ A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G);
           
      (h) ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) ☐ Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).

     

    ITEM 4. OWNERSHIP.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. 

     

    Reporting Persons  Beneficial Ownership(1)   Percentage of Total Ordinary Shares(1)(3)   Sole Voting Power   Shared Voting
    Power (1)
       Sole Dispositive Power   Shared Dispositive Power (1) 
    Sununion Holding Group Limited (2)   12,480,000    57.38%   0    12,480,000    0    12,480,000 
    Gang Lai   12,480,000    57.38%   0    12,480,000    0    12,480,000 

     

     

    (1) Represents the number of ordinary shares beneficially owned by Gang Lai through Sununion Holding Group Limited as of December 31, 2021.
       
    (2) Sununion Holding Group Limited is owned as to 91.4% and controlled by Gang Lai.
       
    (3) The beneficial ownership percentage is calculated based on 21,750,000 ordinary shares of the Issuer issued and outstanding as of December 31, 2021.

     

    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☐

     

    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

     

    Not applicable.

     

    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

     

    Not applicable.

     

    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

     

    Not applicable.

     

    ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

     

    Not applicable.

     

    ITEM 10. CERTIFICATIONS.

     

    Not applicable.

     

     

     

     

    LIST OF EXHIBITS

     

    Exhibit No.   Description
    99.1   Joint Filing Agreement

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 11, 2022

     

      Sununion Holding Group Limited
       
      /s/ Gang Lai
      Name: Gang Lai
      Title: Sole Director
       
      /s/ Gang Lai
      Name: Gang Lai

     

     

     

    Get the next $UPC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UPC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Universe Pharmaceuticals Inc. (Amendment)

      SC 13G/A - Universe Pharmaceuticals INC (0001809616) (Subject)

      2/14/23 2:14:41 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Universe Pharmaceuticals Inc.

      SC 13G - Universe Pharmaceuticals INC (0001809616) (Subject)

      2/11/22 8:00:43 AM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by Universe Pharmaceuticals Inc.

      SC 13G - Universe Pharmaceuticals INC (0001809616) (Subject)

      12/28/21 4:10:53 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $UPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Universe Pharmaceuticals INC Announces Share Consolidation

      Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the "Share Consolidation"). As a result of the Share Consolidation, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders. Th

      3/20/25 8:30:00 AM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

      Ji'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (the "Form 20-F") and that this matter serves as an additional basis for delisting the Company's securities from Nasdaq. The failure to timely file the Form 20-F is a violation of Nasdaq Listing Rule 5250(c)(1). The Com

      2/25/25 4:10:00 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

      Ji'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a letter from the Nasdaq Stock Market LLC ("Nasdaq") on January 29, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore no longer complies with the Nasdaq Listing Rule 5550(a)(2) (the "Rule"). Normally, a company w

      2/3/25 4:10:00 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $UPC
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Universe Pharmaceuticals Inc.

      SCHEDULE 13G/A - Universe Pharmaceuticals INC (0001809616) (Subject)

      5/15/25 6:07:40 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 20-F filed by Universe Pharmaceuticals Inc.

      20-F - Universe Pharmaceuticals INC (0001809616) (Filer)

      4/29/25 4:05:32 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Universe Pharmaceuticals Inc.

      6-K - Universe Pharmaceuticals INC (0001809616) (Filer)

      3/20/25 8:33:28 AM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $UPC
    Leadership Updates

    Live Leadership Updates

    See more
    • Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

      Ji'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating Officer, effective December 1, 2021. Mr. Baochang Liu has over 17 years of experience in pharmaceutical marketing. Mr. Baochang Liu has been working as the vice president of marketing and general manager of OTC department at China Shineway Pharmaceutical Group Ltd. since December 2019. Mr. Baochang Liu served as the general manager of OTC department at Chengdu Kanghong Pharmaceutical Group Co., Ltd. from November 2015 to December 2019. Prior

      12/15/21 4:30:00 PM ET
      $UPC
      Biotechnology: Pharmaceutical Preparations
      Health Care